Back

prof. dr. B. Oldenburg

Full Professor
  1. Contact
  2. Research Programs
  3. Side Activities
  4. Research Output
E. boldenbu@umcutrecht.nl
  • Gastroenterology and Hepatology

Research Programs

Infection & Immunity

Side Activities

  • Advisory board membership: Takeda, Cablon, Ferring, Abbvie, Janssen, Pfizer, dr. Falk 

    Unrestricted grants: Takeda, Abbvie, Janssen

    Chair of the post-graduate teaching program of the Dutch Society of Gastroenterology

    Auditor of the Dutch GI fellow training program

    Member of the Dutch Initiative on Crohn and Colitis (ICC) and the IBD section of the NVMDL

     

Research Output (191)

Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease:A Post Hoc Analysis of TAILORIX

Rivière Pauline, DʼHaens Geert, Peyrin-Biroulet Laurent, Baert Filip, Lambrecht Guy, Pariente Benjamin, Bossuyt Peter, Buisson Anthony, Oldenburg Bas, Vermeire Séverine, Laharie David 10 nov 2020, In: American Journal of Gastroenterology. 116 , p. 134-141 8 p.

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease:retrospective long-term follow-up of the LIR!C trial

Stevens Toer W., Haasnoot Maria L., D'Haens Geert R., Buskens Christianne J., de Groof E. Joline, Eshuis Emma J., Gardenbroek Tjibbe J., Mol Bregje, Stokkers Pieter C.F., Bemelman Willem A., Ponsioen Cyriel Y., Hart Ailsa, Warusavitarne Janindra, Van Bodegraven Ad A., Brink Menno A., Consten Esther C.J., Van Wagensveld Bart A., Rijk Marno C.M., Crolla Rogier M.P.H., Noomen Casper G., Houdijk Alexander P.J., Mallant Rosalie C., Boom Maarten, Marsman Willem A., Stockmann Hein B., De Groof A. Jeroen, Bruin Karlien, Maring John, van Ditzhuijsen Theo, Prins Hubert, van den Brande Jan, Kingma Paul, van Geloven Anna, de Boer Nanne, van der Peet Donald, Jansen Jeroen, Gerhards Michael, van der Woude Janneke, Schouten Ruud, Oldenburg Bas, van Hillegersberg Richard, West Rachel, Mannaerts Guido, Spanier Marcel, Spillenaar Bilgen Ernst Jan, Lieverse Rob, van der Zaag Edwin, Depla Annekatrien, van de Laar Arnold, Mahmmod Nofel, okt 2020, In: The Lancet Gastroenterology and Hepatology. 5 , p. 900-907 8 p.

Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse events

Asscher Vera E R, van der Vliet Quirine, van der Aalst Karen, van der Aalst Anniek, Brand Eelco C, van der Meulen-de Jong Andrea E, Oldenburg Bas, Pierik Marieke J, van Tuyl Bas, Mahmmod Nofel, Maljaars P W Jeroen, Fidder Herma H, 28 aug 2020, In: International Journal of Colorectal Disease. 35 , p. 2331-2338 8 p.

Signal Inhibitory Receptor on Leukocytes-1 is highly expressed on lung monocytes, but absent on mononuclear phagocytes in skin and colon

von Richthofen Helen J., Gollnast Doron, van Capel Toni M.M., Giovannone Barbara, Westerlaken Geertje H.A., Lutter Lisanne, Oldenburg Bas, Hijnen Dirk Jan, van der Vlist Michiel, de Jong Esther C., Meyaard Linde 28 aug 2020, In: Cellular Immunology. 357

Systematic review and external validation of prediction models based on symptoms and biomarkers for identifying endoscopic activity in Crohn's disease

Brand Eelco C, Elias Sjoerd G, Minderhoud Itta M, van der Veen Julius J, Baert Filip J, Laharie David, Bossuyt Peter, Bouhnik Yoram, Buisson Anthony, Lambrecht Guy, Louis Edouard, Pariente Benjamin, Pierik Marieke J, van der Woude C Janneke, D'Haens Geert R A M, Vermeire Séverine, Oldenburg Bas, 1 jul 2020, In: Clinical Gastroenterology and Hepatology. 18 , p. 1704-1718 15 p.

Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment

Biemans Vince B C, van der Woude C Janneke, Dijkstra Gerard, van der Meulen-de Jong Andrea E, Löwenberg Mark, de Boer Nanne K, Oldenburg Bas, Srivastava Nidhi, Jansen Jeroen M, Bodelier Alexander G L, West Rachel L, de Vries Annemarie C, Haans Jeoffrey J L, de Jong Dirk, Hoentjen Frank, Pierik Marieke J, 1 jul 2020, In: Alimentary Pharmacology & Therapeutics. 52 , p. 123-134 12 p.

Vedolizumab for Inflammatory Bowel Disease:Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry – Vedolizumab

Biemans Vince B C, van der Woude Janneke, Dijkstra Gerard, van der Meulen-de Jong Andrea E, Oldenburg Bas, de Boer Nanne K H, Löwenberg Mark, Srivastava Nidhi, Bodelier Alexander G L, West Rachel, Jansen Jeroen M, de Vries Annemarie C, Haans Jeoffrey J L, de Jong Dirk J, Pierik Marie J, Hoentjen Frank, mei 2020, In: Clinical Pharmacology and Therapeutics. 107 , p. 1189-1199 11 p.

Tofacitinib for ulcerative colitis:results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry

Biemans Vince B C, Sleutjes Jasmijn A M, de Vries Annemarie C, Bodelier Alexander G L, Dijkstra Gerard, Oldenburg Bas, Löwenberg Mark, van Bodegraven Adriaan A, van der Meulen-de Jong Andrea E, de Boer Nanne K H, Srivastava Nidhi, West Rachel L, Römkens Tessa E H, Horjus Talabur Horje Carmen S, Jansen Jeroen M, van der Woude C Janneke, Hoekstra Jildou, Weersma Rinse K, van Schaik Fiona D M, Hoentjen Frank, Pierik Marieke J, 1 apr 2020, In: Alimentary Pharmacology & Therapeutics. 51 , p. 880-888 9 p.

Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease

Dreesen Erwin, Baert Filip, Laharie David, Bossuyt Peter, Bouhnik Yoram, Buisson Anthony, Lambrecht Guy, Louis Edouard, Oldenburg Bas, Pariente Benjamin, Pierik Marieke, van der Woude C Janneke, D'Haens Geert, Vermeire Séverine, Gils Ann mrt 2020, In: Clinical Gastroenterology and Hepatology. 18 , p. 637-646.e11

Vulvar and vaginal neoplasia in women with inflammatory bowel disease

Rouvroye Maxine D., Tack Greetje J., Mom Constantijne H., Lissenberg-Witte Birgit I., Pierik Marieke J., Neefjes-Borst E. Andra, de Boer Nanne K.H., Löwenberg M., Bodelier A., Verbeek W. H., Schoon E., Witteman E. M., Herwaarden M. A., Van Der Woude C. J., Lutgens M., Kouw E., Van Der Veek P. J., van der Hulst R. W., Sipkema H., Nissen L. H.C., Bus P. J., van der Meulen A. E., De Bruijne F. H., van der Waaij L. A., Noomen C. G., Jharap B., Schmittgens S., Jansen J. M., Hoentjen F., Lammertink M. H.A., Houben G. M.P., Minderhoud I. M., Dijkstra G., Oldenburg B., Sikkens M. S.G., Van Tuyl S. A., van Bodegraven A. A., feb 2020, In: Digestive and liver disease. 52 , p. 149-155 7 p.

All research output